|
|
|
| United States Patent | 4957114 |
| Link to this page | http://www.wikipatents.com/4957114.html |
| Inventor(s) | Zeng; Kun (all, of No. 77 Jiangning Lu, Shanghai, CN);
Wu; Jinrong (all, of No. 77 Jiangning Lu, Shanghai, CN);
Yang; Sen (all, of No. 77 Jiangning Lu, Shanghai, CN);
Yu; Zhenfen (all, of No. 77 Jiangning Lu, Shanghai, CN);
Zhu; Jiude (No. 111 Zun Yi Lu, Shanghai, CN) |
| Abstract | This invention relates to a diagnostic apparatus and particularly to an
apparatus for the diagnosis of malignant tumor and the method of using the
apparatus for diagnosis. The apparatus employs an ultraviolet light source
with an emitting waveband of 3000A-4000A. Light from the light source is
transmitted through a bundle of quartz optic fibers to the surface of the
tumor, whether benign or malignant, to stimulate it, which then generates
a specific intrinsic fluorescence spectrum. The intrinsic fluorescence
spectrum reflected from the surface of the tumor is transmitted by a
second bundles of glass fibers placed near it to a color resolution means,
then processed by a scanning means and a circuit means, and displayed
recorded by a display recording means. The display may be a graphic
presentation of the intrinsic fluorescence spectrum of the tumor that is
tested. If the graphic presentation displayed includes a single peak
within the range of the blue color band, it indicates that the tumor being
tested is benign. If however, a second peak appears within the range of
the red color band of the graphic presentation it is a characteristic peak
of malignancy, indicating the existence of a malignant tumor. The presence
of the red color can be established by eye rather than a complex color
resolution system. |
|
|
|
Title Information  |
|
|
|
|
|
Drawing from US Patent 4957114 |
|
|
Diagnostic apparatus for intrinsic fluorescence of malignant tumor |
|
| Inventor |
Zeng; Kun (all, of No. 77 Jiangning Lu, Shanghai, CN);
Wu; Jinrong (all, of No. 77 Jiangning Lu, Shanghai, CN);
Yang; Sen (all, of No. 77 Jiangning Lu, Shanghai, CN);
Yu; Zhenfen (all, of No. 77 Jiangning Lu, Shanghai, CN);
Zhu; Jiude (No. 111 Zun Yi Lu, Shanghai, CN) |
|
|
|
| Publication Date |
September 18, 1990 |
|
|
|
|
|
| Filing Date |
June 28, 1988 |
|
|
|
|
|
|
|
|
|
|
|
| Parent Case |
This is a continuation of application Ser. No. 843,950 filed Mar. 25, 1986,
now abandoned. |
|
| Priority Data |
Apr 01, 1985[CN]85100424 |
|
|
|
|
|
|
|
|
|
|
|
Title Information  |
|
|
Description  |
|
|
FIELD OF INVENTION
This invention relates to a diagnostic apparatus and particularly to an
apparatus for use in the diagnosis of a malignant tumor and to the method
of using the apparatus for diagnosis.
BACKGROUND ART
A paper entitled "The Study of the Analysis of Laser Stimulated
Fluorescence Spectrum of the Digestive System and the Nature of it's
Fluorescent Material," relating to the use of an argon laser having a
wavelength of 5145 A as a light source has appeared in the Journal of the
Japanese Association for Digestive Organ Endoscopy, Vol. 26, 8 Aug. 1984.
The paper, more particularly, demonstrates the use of such an argon laser
as a light source for directly illuminating an isolated specimen from the
body and analyzing the intrinsic fluorescence spectrum generated by the
light source to determine whether a malignant tumor exists in the isolated
specimen. It has been found, however, that the method cannot be used
satisfactory to diagnose gastric cancer, and its accuracy in the diagnosis
of cancer of the large intestine was found to be only 30%. This is because
the blue-green light of the argon-ion laser is visible light that
superimpose upon the visible light waveband of the fluorescence spectrum
generated by its stimulation on the isolated speciment, which is liable to
lead to erroneous diagnosis. Moreover, the research studies embodied in
this paper are only in the stage of experimentation, and up to this time
no complete apparatus has achieved a satisfactory diagnosis of a malignant
tumor.
DISCLOSURE OF THE INVENTION
It is a primary object of the invention to provide a diagnostic apparatus
and method to improve the accuracy of diagnosis of a malignant tumor.
It is another object of the invention to provide an apparatus capable of
rapid operation, and one which may be used simply and in a non-invasive
manner to clinically diagnose malignant tumors of various kinds, as well
as provide a method of using the apparatus diagnostically.
A further object of the invention is to provide a diagnostic apparatus that
uses a high energy light source with specific wavelengths in order to
increase the sensitivity of the diagnosis.
Additional objects, advantages and other novel features of the invention
are set forth in the description that follows, and other objects,
advantages and features will become apparent to those skilled in the arts
to which the invention pertains.
The objects and advantages of the invention may be realized and attained
through improvement of the light source and light transmitting means for
stimulating and transmitting the intrinsic fluorescence of a tumor.
Particularly, an improved diagnostic apparatus is provided to stimulate
the intrinsic fluorescence of a tumor and determine according to the
spectrum and color of said fluorescence whether the tumor is benign or
malignant. The apparatus provides an ultraviolet light source with an
emitting waveband of 3000 A-4000 A. Light from the light source is
transmitted through a bundle of quartz optical fibers to the surface of
the tumor whether benign or malignant, to stimulate it, which then
generates a specific intrinsic fluorescence spectrum. The intrinsic
fluorescence spectrum generated by the tumor is transmitted by a second
bundle of ordinary glass fibers placed near it to a color resolution
system.
The spectrum can be processed by an automatic scanning system and an
electric system, and both displayed and recorded by a display recording
system.
The display may be a graphic presentation of the intrinsic fluorescence
spectrum of the tumor that is tested. If the graphic presentation
displayed includes a single peak within the range of the blue color band,
it indicated that the tumor being tested is benign. If, however, a second
peak appears within the range of the red color band of the graphic
presentation, the second peak is representative of tissue demonstrating
the existence of malignancy.
As compared with the prior art, the apparatus of the invention
advantageously uses a near ultraviolet light source with an emitted
wavelength of 3000 A-4000 A, rather than an argon-ion laser. Since the
energy of the stimulating beam is greatly increased and the emitted
wavelength of the light source is closer to the absorbed peak value of
3400 A.+-.200 A by a malignant tumor, the apparatus provides increased
sensitivity and therefore accuracy of diagnosis. More importantly, since
the near ultraviolet waveband emitted by the light source is invisible,
while the intrinsic fluorescence stimulated by the light source is
visible, the intrinsic fluorescence spectrum from the tumor is a visible
spectrum without any superpositioning of the light spectrum from the light
source. This has the effect of significantly increasing the accurate of
the diagnosis of a malignant tumor by the apparatus of the invention. To
this end the apparatus is able to diagnose malignant tumors 1-2 mm in
thickness in the mucosa or submucosa. This capability is of great
importance in early diagnosis of cancer.
The apparatus embodies soft, flexible fiber optics cables to transmit
stimulating light from the light source to the surface of the tumor
tissue, and to transmit the intrinsic fluorescence from the tumor to the
color resolution system. The apparatus is easy to operate and may be used
to diagnose malignancy on a body surface or within a body cavity. Thus,
the flexible fiber optics cables may function as an endoscope and this
also can be used to guide the surgeon to define the position and the
extent of a malignancy exposed in a field of operation.
The apparatus is simple and non-invasive in operation and attains high
diagnostic accuracy in use. The apparatus may be used widely to diagnose a
malignancy of a biological speciment or in general investigation. Four
hundred and six cases of various kinds of malignancies were verified
through use of the apparatus at the Central Hospital of Changning
District, Shanghai, China, the Shanghai Municipal Tumor Hospital, and the
Obstetrical and Gynecological Hospital of Shanghai, China, a hospital
affiliated with the Shanghai First Medical College. The apparatus provided
a demonstrated accuracy of 90 percent.
A preferred embodiment of the invention and the best mode suited to carry
out the invention are illustrated in the drawings and further described as
the description continues. As may be understood, however, the invention is
capable of other difference embodiments, and its several details are
capable of modification all without departing from the spirit of the
invention. Accordingly the drawings and the description that follow should
be regarded as illustrative in nature.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a block drawing of the diagnostic apparatus of the invention.
FIG. 2 is a diagrammatic view of the structure of light source system and
light transmitting system.
FIG. 3 illustrates the intrinsic fluorescence spectrum of living tissue
that is normal.
FIG. 4 illustrates the intrinsic fluorescence spectrum of living tissue
that is cancerous.
BRIEF DESCRIPTION OF THE PREFERRED EMBODIMENT
With reference to FIG. 1, the diagnostic apparatus for intrinsic
fluorescence of malignant tumor includes a light source system (1) for
emitting near ultraviolet light having a wavelength of 3000 A-4000 A. A
cable (2) comprised of a bundle of quartz optical fibers is connected to
the light source to transmit the light emitted from the light source to
the tissue (3) be tested. A second cable (4) of ordinary glass optical
fibers is located in a position relative to the tissue to receive the
intrinsic fluorescence of the living tissue stimulated by the near
ultraviolet light. The cable (4) for transmitting the intrinsic
fluorescence from the simulated living tissue is connected to a color
resolution system (5) such a conventional prism or grating.
As shown in the figure, the output of the color resolution system can be
fed into an electric circuit system (6) (usually a conventional
photomultiplier tube and associate amplification circuitry). The electric
circuit system, as is conventional in optical systems, can control a
display recording system (7) and an automatic scanning system (8) which,
in tune can control the color resolution system with a 0.5 second scan. If
desired, an alarm system (9) can be connected to the display recording
system.
Referring to FIG. 2, light source system (1) includes a mercury lamp (10)
and reflecting bowl (11). Both the mercury lamp and the reflecting bowl
are fixed on a stand (12) within a housing. The reflecting bowl reflects
the light emitted from the mercury lamp toward the center of an
ultraviolet filter which forms an excellent, single stimulating light of
3650 A closing to the best functioning waveband 3400.+-.200 A. The focus
of the light toward the center of a stack of plates is carried out through
adjustment of adjustable stand (12). The stacked plates comprising the
ultraviolet filter may include from four to twelve superposed plates in
number, and each plate may have a thickness of 1-2 mm.
As indicated, the cables (2) and (4) comprise a light transmitting system
for transmitting the stimulating light from the light source system to the
surface of the tumor (3) and the intrinsic fluorescence of the tumor to
the color resolution system. The system may be formed as multibundles and
the quartz optical fibers of cable (2) comprise a low energy consuming
multibundle.
With continued reference to FIG. 2, the incident or efferent end of the
optical fibers of cable (2) from which stimulating light impinges on the
surface of the tissue emanates is preferably at an acute angle to the
surface of the tumor, while the reflective or afference end of the optical
fibers of cable (4) for receiving the intrinsic fluorescence is located
perpendicular to the surface of the tumor. The angle of the incident end
of cable (2) to the surface (3) and the reflective end of cable (4) is
about 45.degree.. A fix stand (15) both locates and fixes the position of
the ends of the cable thereby to control the angle between the ends, and
the distance to the surface of the living tissue to be tested. The
distance from the surface of the tumor to the ends of the optic fibers
should be about 2 to 10 mm. A shade (16) similar in size to that of the
fix stand tightly covers the surface of the fix stand. In operation of the
apparatus, the lower end of the shade is firmly attached to the surface of
the tumor to be tested. The shade should be changed after each use to
avoid cross infection as may otherwise result from repeated connection of
the same shade with living tissue.
The near ultraviolet light of 3000 A-4000 A wavelength emitted from the
light source system (1) is transmitted by the cable (2) of quartz optical
fibers to the surface (3) of the tumor. The tumor may comprise normal
tissue or malignant tissue. The light stimulates the tissue to emit an
intrinsic fluorescence. The generated intrinsic fluorescence is
transmitted by the cable (4) of ordinary glass optical fibers to a color
resolution system (5). The color resolution system may be controlled
through a 0.50 second automatic scanning system (8). An electric circuit
system (6) may be used to process the signal for display and to record the
intrinsic fluorescence spectrum.
FIG. 3 illustrates the intrinsic fluorescence spectrum of normal, living
tissue. Normal, living tissue is represented by a spectrum graph with one
peak within the blue color waveband at 4500 A-4800 A. FIG. 4, on the other
hand, illustrates the intrinsic fluorescence spectrum of malignant, living
tissue. In this figure, in additional to the peak with the blue color
wavelength at 4500 A-4800 A, there also appears a characteristic peak
within the red color waveband at 6000 A-6900 A representing malignant
tissue.
A mercury lamp (10) provides advantages in use in the apparatus of the
invention. To this end, the mercury lamp is simpler in construction that
other ultraviolet light sources, is more easily used in operation, and
provides convenient maintenance, at low cost. The mercury lamp may also be
used over extended periods of time. As an alternative, however, the light
source may comprise an ultraviolet laser with the light from the light
source being similarly transmitted to the surface of the living tissue to
stimulate its intrinsic fluorescence. The advantage of the ultraviolet
laser is that the energy of the laser is greater and it has higher
efficiency in stimulating the intrinsic fluorescence of the living tissue.
Thus, the demand of an electric circuit system (6) for processing the
intrinsic florescence may be reduced. The advantages, however, may be
counterbalanced by higher cost of apparatus with an ultraviolet laser.
The ultraviolet laser may comprise any one of a nitrogen laser, krypton
laser, xenon laser and ultraviolet excimer laser apparatus.
Another alternative form of the present invention envisions that the
incident end of cable (2) and the reflective end of cable (4) may be made
into a coaxial construction. This construction has the effect of
diminishing the contact surface between the living tissue and the optic
fibers, and it also decreases the space occupied by optical fibers. The
alternative form of the invention may be resorted to in use of the
apparatus as an endoscope for deep entry into and diagnosis of an inner
cavity of the body. The length of the coaxial construction will be
determined by the depth within the body cavity that is to be reached for
diagnosis.
According to the coaxial construction, the optical fibers of cable (2) for
transmitting stimulating light are made of low energy consumption quartz
glass, and the optic fibers of cable (4) for transmitting intrinsic
fluorescence of living tissue are made of ordinary optical glass. The
optical fibers of cable (2) may be in the form of multibundles or the
cable may comprise a single optical fiber having a diameter of 300u-600u.
The optical fibers of cable (4) may also be in the form of bundles that
surround the optical fibers of cable (2). In addition, the bundles of
optical fibers of cable (2) and (4) may be arranged in an alternating
arrangement in the coaxial construction. It has been found that the
coaxial construction optical fiber is less effective than the noncoaxial
construction of optical fibers. Therefore, the coaxial construction should
be used only when demand dictates its use.
According to the invention, the wave spectrum of the intrinsic fluorescence
of the living tissue is displayed and recorded in the diagnoses of the
presence or absence of a malignancy in the tissue tested. Alternatively,
in the simplest use of the overall method of testing, the color of the
intrinsic fluorescence emitted by the stimulated tissue may be observed
directly by eye. The invention employs a source of ultraviolet light
having an emitting wavelength of 3000 A-4000 A, preferably 3400.+-.-200 A.
Since the wavelength of stimulated intrinsic fluorescence of malignant
tissue lies within the 6000 A-6900 A waveband of red color, the tested
living tissue illuminated by the nearby ultraviolet light source through
cable (2) may be observed by naked eye. If the intrinsic fluorescence
emitted from the tested living tissue is a visible red or of reddish color
the immediate diagnosis is that a malignant tumor exists in the living
tissue that is tested.
Other modifications and variations of the invention may be made within the
scope of the invention and teachings, all as defined by the scope of the
appended claims.
* * * * *
|
|
|
|
|
Description  |
|